FERROPTOSIS AND OXIDATIVE STRESS: A NOVEL THERAPEUTIC TARGET IN EXPERIMENTAL DISEASE MODELS

The article discusses the recovery and effective utilization of bioactive compounds from residual parts of medicinal plants remaining after primary extraction. The composition of flavonoids, phenolic compounds, terpenoids, and other bioactive components, as well as their antioxidant activity and bioaccessibility during gastrointestinal digestion, are considered. The importance of DPPH, ABTS, and the INFOGEST protocol for in vitro evaluation is also highlighted, along with the potential of medicinal plant residues for developing innovative products for the food, cosmetic, and pharmaceutical industries.